Hjem › Follikulært lymfom › Ohio › Columbus
Follikulært lymfom kliniske forsøg i Columbus, OH
13 studier for Follikulært lymfom søger deltagere på steder i og omkring Columbus (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RekruttererFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Epco, Zanu, Ritux for R/R FL or MZL
RekruttererFase 2
- The Ohio State University Wexner Medical Center, Columbus
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- The Ohio State University (OSU), Columbus
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
RekruttererFase 3
- Research Site, Columbus
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruttererFase 2
- Research Site, Columbus
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
RekruttererObservationsstudie
- OhioHealth Research Institute, Columbus
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RekruttererFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- The Ohio State University Wexner Medical Center, Columbus
Epcoritamab and Rituximab for First-line Follicular Lymphoma
RekruttererFase 2
- The Ohio State University Wexner Medical Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruttererFase 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
RekruttererFase 1
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruttererFase 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Follikulært lymfom forsøg i andre byer
- New York City, NY24 studier
- Milwaukee, WI19 studier
- Nashville, TN18 studier
- Houston, TX18 studier
- Boston, MA17 studier
- Baldwin Park, CA16 studier
- Seattle, WA15 studier
- Durham, NC15 studier
- Salt Lake City, UT13 studier
- San Antonio, TX12 studier
- Chicago, IL12 studier
- Philadelphia, PA12 studier
Andre studier i Columbus
- Ikke-småcellet lungecancer56 studier
- Brystkræft39 studier
- Ægstockræft39 studier
- Kræft (alle typer)38 studier
- Lungecancer37 studier
- Akut myeloid leukæmi35 studier
- Kronisk lymfatisk leukæmi28 studier
- Metastatisk cancer27 studier
- Livmoderslimhindekræft25 studier
- Colorektal kræft24 studier
- Prostatakræft24 studier
- Multipelt myelom24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.